Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
RCT
ACE Report #6209
Ace Report Cover General Orthopaedics

WCO-IOF: Rituximab positively impacts QOL in patients with rheumatoid arthritis


Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A

Effect of rituximab therapy on life quality with rheumatoid arthritis patients

Contributing Authors: MV Koroleva TA Raskina

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CONFERENCE ACE REPORTS

This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.

Synopsis

98 patients diagnosed with rheumatoid arthritis (RA) were randomized to receive methotrexate with or without rituximab therapy to determine effect of rituximab on quality of life in this patient population. The Euro-QOL 5 dimension (EQ-5D) and Health Assessment Questionnaire for Rheumatoid Arthritis (HAQ) were assessed over 24 months. Upon analysis, combined methotrexate and rituximab therapy achi...

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.